Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-19T04:35:53.905Z Has data issue: false hasContentIssue false
  • English
  • Français

Subtyping of Mycobacterium avium complex (MAC) isolates by thin-layer chromatography – distribution of subtypes from patients with AIDS compared with clinically non-significant isolates

Published online by Cambridge University Press:  15 May 2009

W. Chew ,
T. C. Sorrell  and
G. L. Gilbert
W. Chew
Affiliation:
Department of Clinical Microbiology, Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia
T. C. Sorrell
Affiliation:
Department of Clinical Microbiology, Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia
G. L. Gilbert
Affiliation:
Department of Clinical Microbiology, Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Thin-layer chromatography (TLC) was compared with seroagglutination for subtyping of Mycobacterium avium complex (MAC) bacteria. Seventy-five significant MAC isolates from patients with AIDS were typed by both methods and 36 isolates, judged to be clinically non-significant, were examined by TLC only. Overall. 75% of isolates tested were typable by seroagglutination and 91% by TLC; the results correlated between the two except for minor discrepancies.

Serovars 1, 8 and 21 and mixed serovars 1–21 and 1–8–21 were common among isolates from AIDS patients and together represented 83 % of isolates compared with only 36% in the non-significant group (odds ratio 8·4; 95% confidence interval 3·4–23·3). This difference remained significant after exclusion of serovar 41 (M. scrofulaceum), which was the commonest isolate (28%) in the non-significant group but was not isolated from patients with AIDS.

TLC is useful to supplement seroagglutination for subtyping of MAC. Further study is required to determine whether apparent differences between isolates from patients with AIDS and from other sources reflect differences in virulence or in environmental prevalence of MAC subtypes.

Type
Research Article
Information
Epidemiology & Infection , Volume 112 , Issue 3 , June 1994 , pp. 543 - 549
Copyright
Copyright © Cambridge University Press 1994

References

REFERENCES

1.Young, LS, Inderlied, CB, Berlin, OG, Gottlieb, MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986; 8: 1024–33.CrossRefGoogle ScholarPubMed
2.Schaefer, WM. Serological identification of atypical mycobacteria. Methods Microbiol 1980; 13: 323–44.CrossRefGoogle Scholar
3.Tsang, AY, Denner, JC, Brennan, PJ, McClatchy, JK. Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates. J Clin Microbiol 1992; 30: 479–84.CrossRefGoogle ScholarPubMed
4.Brennan, PJ, Heifets, M, Ullom, BP. Thin-layer chromatography of lipid antigens as a means of identifying nontuberculous mycobacteria. J Clin Microbiol 1982; 1115; 447–55.CrossRefGoogle Scholar
5.Meissner, PC, Falkinham, JO. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis 1986; 1553; 325–31.Google Scholar
6.Gangadharam, PRJ, Perumal, VK, Crawford, JT, Bates, JH. Association of plasmids and virulence of Mycobacterium avium complex. Am Rev Resp Dis 1988; 137; 212–14.CrossRefGoogle ScholarPubMed
7.Hellyer, TJ, Brown, IN, Dale, JW, Easmon, CSF. Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS. J Med Microbiol 1991; 34; 225–31.CrossRefGoogle ScholarPubMed
8.Hampson, SJ, Portaels, F, Thompson, J et al. , DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet 1989; i: 65–6.CrossRefGoogle Scholar
9.Dawson, DJ. Infection with Mycobacterium avium complex in Australian patients with AIDS. Med J Aust 1990; 153: 466–8.Google Scholar
10.Wolinsky, E. Mycobacterial disease other than tuberculosis. Clin Infect Dis 1992; 15: 1–12.CrossRefGoogle ScholarPubMed
11.Wayne, LG, Sramek, HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5; 1–25.Google Scholar
12.Nightingale, SD, Byrd, LT, Southern, PM, Jockusch, JD, Cal, SX, Wynne, BA. Incidence of Mycobacterium avium-intracellulare complex bacteraemia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 1665; 1082–5.Google Scholar
13.Kerlikowski, KM, Katz, MH, Chan, AK, Perez-Stable, EJ. Antimycobacterial therapy in disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Arch Intern Med 1992; 152; 813–17.CrossRefGoogle Scholar
14.Guthertz, LS, Damsker, B, Bottone, EJ, Gord, EG, Midura, TF, Janda, JM. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis 1989; 160: 1037–41.Google Scholar
15.Falkinham, JO, Parker, BC, Gruft, H. Epidemiology of infection by nontuberculous mycobacteria. 1. Geographic distribution in the Eastern United States. Am Rev Resp Dis 1980; 121: 931–7.Google ScholarPubMed
16.Horsburgh, Jr CR, Cohn, DL, Roberts, RB et al. , Mycobacterium avium–M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome. Antimicrob Agents Chemother 1986; 30; 955–7.CrossRefGoogle ScholarPubMed
17.Yakrus, YA, Good, RC. Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990; 28; 926–9.Google Scholar
18.Hoffner, SE, Petrini, B, Brennan, PJ, Tsang, AY, Kallenius, G. AIDS and Mycobacterium avium serovars in Sweden. Lancet 1989; ii: 336–7.CrossRefGoogle Scholar
19.Ruf, B, Peters, M, Schroeder, H-J, Pohle, HD. Mycobacterium avium-intracellulare serovars in German AIDS patients. Lancet 1989; ii: 1101.CrossRefGoogle Scholar
20.du Moulin, GC, Stottmeier, KD, Pelletier, PA, Tsang, AY, Hedley-Whyte, J. Concentration of Mycobacterium avium by hospital hot water systems. JAMA 1988; 260; 1599–601.Google Scholar